TWiV 1018: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses the CDC vaccine advisory group recommending the newly approved RSV vaccines, association of culturable-virus detection and household transmission of SARS-CoV-2, prevention of COVID-19 following a single intramuscular administration of Adintrevimab, real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19, and COVID-19 convalescent plasma outpatient therapy to prevent outpatient hospitalization. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode CDC vaccine advisory group recommends RSV vaccines Association of culturable-virus detection and household transmission of SARS-CoV-2 (JID) Prevention of COVID-19 following intramuscular administration of Adintrevimab (OFID) Real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19 (CID) COVID-19 convalescent plasma outpatient therapy to prevent hospitalization (CID) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1018 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

Om Podcasten

TWiV is a weekly netcast about viruses - the kind that make you sick. Professors Vincent Racaniello, Dickson Despommier, Rich Condit, Kathy Spindler and science writer Alan Dove and guests deconstruct viruses, how they cause illness, and dissect the latest research.